Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Shares Outstanding (Weighted Average) (2016 - 2020)

Historic Shares Outstanding (Weighted Average) for Monopar Therapeutics (MNPR) over the last 4 years, with Q3 2020 value amounting to $11.1 million.

  • Monopar Therapeutics' Shares Outstanding (Weighted Average) rose 1964.16% to $11.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $11.1 million, marking a year-over-year increase of 1964.16%. This contributed to the annual value of -$0.83 for FY2022, which is N/A changed from last year.
  • Monopar Therapeutics' Shares Outstanding (Weighted Average) amounted to $11.1 million in Q3 2020, which was up 1964.16% from $10.6 million recorded in Q2 2020.
  • In the past 5 years, Monopar Therapeutics' Shares Outstanding (Weighted Average) registered a high of $11.1 million during Q3 2020, and its lowest value of $8.3 million during Q1 2017.
  • In the last 4 years, Monopar Therapeutics' Shares Outstanding (Weighted Average) had a median value of $9.3 million in 2018 and averaged $9.4 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first changed by 0.0% in 2019, then skyrocketed by 1964.16% in 2020.
  • Over the past 4 years, Monopar Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $8.8 million in 2017, then grew by 5.8% to $9.3 million in 2018, then increased by 0.32% to $9.3 million in 2019, then grew by 19.26% to $11.1 million in 2020.
  • Its last three reported values are $11.1 million in Q3 2020, $10.6 million for Q2 2020, and $10.6 million during Q1 2020.